Pharma Mergers and Acquisitions


Pharma IQ
06/13/2017

Despite the volume of deals dipping, pharma companies paid a lot more for mergers and acquisitions in 2016. The FT reports that the value of deals increased by almost double.

Despite the volume of deals dipping, pharma companies paid a lot more for mergers and acquisitions in 2016. The FT reports that the value of deals increased by almost double.